Dopamine is a chemically simple molecule with an outsized role in the nervous system. It acts as a neurotransmitter, carrying signals between nerve cells and helping regulate movement, motivation, reward, attention and several other physiological processes. Abnormal dopamine signaling is associated with neurological and psychiatric conditions including Parkinson’s disease, Alzheimer’s disease and schizophrenia. Yet measuring dopamine outside a laboratory is difficult. The molecule is present in complex mixtures alongside compounds such as ascorbic acid and uric acid, which can generate similar electrical responses at an electrode. Dopamine concentrations can also change rapidly and vary substantially between biological compartments, meaning that a useful sensor must be sensitive, selective, fast and capable of working with very small sample volumes.

The new device uses electrochemistry to solve part of that problem. Rather than identifying dopamine through a bulky analytical instrument, the sensor measures the current produced when dopamine undergoes oxidation at the electrode surface. The resulting electrical signal depends on the amount of dopamine available to react. In practice, however, an unmodified electrode may provide a weak or poorly resolved response. The researchers therefore coated a screen-printed electrode with a composite engineered to improve several stages of the sensing process at once. The resulting MX-CD-Au/SPE sensor uses MXene as a conductive framework, banana-peel carbon dots as functional nanoscale components and gold nanoparticles to increase catalytic activity and facilitate electron transfer.

MXenes are two-dimensional transition-metal carbides or nitrides known for their electrical conductivity, hydrophilic surfaces and large effective area. Their sheet-like structure can provide abundant sites where target molecules interact and where electrochemical reactions occur. In the composite, MXene acts as a conductive highway, allowing electrons generated during dopamine oxidation to move efficiently toward the electrode. Its surface chemistry can also support the attachment and distribution of other nanomaterials. The researchers paired it with gold nanoparticles, which are widely used in electrochemical sensing because their high surface area and favorable electronic properties can accelerate redox reactions. Together, the materials were intended to amplify the signal without requiring a large electrode or a conventional laboratory setup.

The third component, carbon dots produced from banana peel, adds a sustainability angle as well as chemical functionality. Carbon dots are nanoscale carbon particles with abundant surface groups that can influence how molecules bind and how electrons are transferred. In this design, the bio-derived dots were distributed with MXene and gold, creating a hybrid surface rather than three isolated materials operating independently. Structural and morphological characterization confirmed that the components had been integrated uniformly, according to the researchers. That architecture is important because a composite’s performance depends not only on the properties of its ingredients but also on how closely those ingredients contact one another. Efficient interfaces can reduce resistance to electron movement and expose more active sites to the sample.

The sensor produced a linear response to dopamine from 2 to 914 micromolar and reported a detection limit of 0.15 micromolar. A linear range means that, within those limits, changes in dopamine concentration correspond predictably to changes in the measured electrochemical signal, allowing an unknown sample to be quantified against a calibration curve. The low detection limit indicates that the device could register relatively small amounts of dopamine under the reported experimental conditions. The researchers also tested selectivity in the presence of common interferents, a critical challenge for real biological samples. According to the study, the MX-CD-Au/SPE platform retained a strong dopamine response despite those competing substances, suggesting that the engineered surface improved discrimination as well as sensitivity.

To test whether the chemistry worked beyond prepared solutions, the team examined several increasingly realistic biological settings. First, they added known amounts of dopamine to rat brain homogenate, a complex mixture containing proteins, salts, metabolites and cellular debris. The sensor quantified the spiked neurotransmitter in that matrix, demonstrating that the response was not limited to a clean laboratory solution. The researchers then monitored dopamine released from human SH-SY5Y neuroblastoma cells after stimulation with potassium ions. Raising extracellular potassium concentration depolarizes cell membranes, encouraging electrically excitable cells to release signaling molecules. Detecting the resulting extracellular dopamine provided an in vitro test of whether the sensor could follow a biologically generated signal rather than merely measure a prepared standard.

The platform’s most attention-grabbing feature is its one-drop format. Instead of requiring milliliters of sample, the system is designed to analyze a microvolume droplet placed directly on the sensing area. The researchers integrated the electrode with a smartphone-compatible portable device and used it to quantify dopamine in droplets of human sweat. Sweat is attractive for non-invasive monitoring because it can be collected without needles, although it is chemically variable and generally does not provide a direct readout of neurotransmitter levels in the brain. A sweat measurement therefore should not be interpreted as a simple substitute for neural sampling. It is better understood as a demonstration that the sensor can operate in a readily accessible biological fluid while using only a very small amount of material. The study reports that sample collection followed the Declaration of Helsinki, received institutional review approval and involved informed consent.

The work illustrates how several trends in biosensing are converging: nanostructured electrodes, waste-derived materials, smartphone integration and microvolume analysis. Screen-printed electrodes are especially useful for portable devices because they can be manufactured inexpensively and in compact formats, while smartphones can provide display, processing and connectivity without adding a dedicated laboratory instrument. A one-drop system could eventually support rapid measurements in settings where centralized testing is impractical. However, substantial barriers remain before such a platform could be used to diagnose or manage disease. Future studies would need to establish long-term stability, calibration across individuals, resistance to sweat composition differences, manufacturing reproducibility, storage life, clinical accuracy and the relationship between peripheral dopamine measurements and neurological status. The current findings show that the composite can detect dopamine in several experimental matrices; they do not yet demonstrate clinical diagnosis, continuous wearable operation or direct measurement of dopamine inside the human brain. Funded by the National Research Foundation of Korea, the study nevertheless presents a striking example of how a discarded fruit peel and advanced nanomaterials could be combined into a pocket-sized tool for real-time chemical sensing.

Using a sophisticated mouse model of narcolepsy, the research team observed that social reunification—a highly positive social stimulus—precipitated episodes of cataplexy. Intriguingly, administration of an oxytocin antagonist was able to effectively block these socially induced cataplexy events, strongly implicating oxytocin signaling in the amygdala as a driving force behind the phenomenon.

High-resolution neurochemical monitoring revealed an increase in oxytocin tone just before the onset of cataplexy triggered by social cues. This was accompanied by heightened activity in oxytocin receptor-expressing neurons within the central amygdala, an emotional brain region known for its role in processing social behaviors and affective states. These findings suggest that oxytocin acts centrally to prime neural circuits that facilitate the transition into cataplexy.

Delving deeper, the study employed advanced chemogenetic and optogenetic methods to manipulate oxytocin-responsive neuronal populations directly. Activation of these central amygdala neurons resulted in the inhibition of specific brainstem neurons responsible for suppressing muscle atonia. In essence, the oxytocin-responsive amygdala neurons were shown to disinhibit the muscle atonia circuits, thereby triggering cataplexy.

What makes this discovery even more compelling is the identification that rewarding stimuli beyond social interaction can engage the same oxytocin–amygdala pathway. Chocolate, a potent and universally rewarding food stimulus known to evoke strong positive emotions, was found to induce cataplexy episodes in narcoleptic mice through activation of this same neural circuit.

This research not only clarifies the neural underpinnings of emotionally triggered cataplexy but also highlights the central amygdala as a potential target for therapeutic intervention. By modulating oxytocin signaling or selectively targeting oxytocin-responsive neurons in the amygdala, future treatments may be designed to suppress cataplexy without broad suppression of emotion or social engagement.

The implications extend beyond narcolepsy alone, offering fresh insights into how socio-affective brain circuits interface with motor control systems to affect muscle tone. This may inspire new lines of inquiry into the wider neurobiology of emotion-driven motor phenomena.

Overall, these findings expertly illustrate the complex interplay between neuropeptides, emotional processing centers, and motor inhibition pathways, opening promising avenues for managing one of narcolepsy’s most disruptive symptoms through targeted neurochemical modulation.

Subject of Research:
Article Title:
Article References: Mahoney, C.E., De Luca, R., Joyal, A.A. et al. Oxytocin promotes socially triggered cataplexy. Nat Neurosci (2026). https://doi.org/10.1038/s41593-026-02352-7
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41593-026-02352-7
Keywords: Narcolepsy, Cataplexy, Oxytocin, Central Amygdala, Muscle Atonia, Social Interaction, Reward, Chemogenetics, Optogenetics